Format

Send to

Choose Destination
Nat Biotechnol. 2015 Jul;33(7):689-93. doi: 10.1038/nbt.3237.

Good laboratory practice for clinical next-generation sequencing informatics pipelines.

Author information

1
Division of Laboratory Systems, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
2
Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
3
Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USA.
4
1] Laboratory for Molecular Medicine, Partners Healthcare Personalized Medicine, Cambridge, Massachusetts, USA. [2] Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.
5
1] Department of Genetics, Washington University School of Medicine, St. Louis, Missouri, USA. [2] Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA. [3] Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
6
Department of Physiology and Biophysics, Cornell University, New York, New York, USA.
7
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
8
1] Department of Pathology, University of Utah, Salt Lake City, Utah, USA. [2] Institute for Clinical and Experimental Pathology, Associated Regional and University Pathologists (ARUP) Laboratories, Salt Lake City, Utah, USA.
9
College of American Pathologists, Northfield, Illinois, USA.
10
National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
11
Division of Laboratory Services, Centers for Medicare and Medicaid Services, Baltimore, Maryland, USA.
12
Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland, USA.
13
National Center for Biotechnology Information, National Institutes of Health, Bethesda, Maryland, USA.
14
Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
15
Division of Select Agents and Toxins, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
16
GenomeQuest, Westborough, Massachusetts, USA.
17
Clinical Services, Illumina, San Diego, California, USA.
18
Thermo Fisher Scientific, South San Francisco, California, USA.
19
Texas Children's Microbiome Center, Texas Children's Hospital and Department of Pathology &Immunology, Baylor College of Medicine, Houston, Texas, USA.
20
National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia USA.
21
Illumina, San Diego, California, USA.
22
SoftGenetics, State College, Pennsylvania, USA.
23
Oncology, Illumina, San Diego, California, USA.
24
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
25
Department of Pathology, University of Utah, Salt Lake City, Utah, USA.
26
Material Measurement Laboratory, National Institute of Standards and Technology, Gaithersburg, Maryland, USA.
PMID:
26154004
DOI:
10.1038/nbt.3237
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center